Is normal saline (NS) acceptable for hydration in a patient with mild ketonuria and euglycemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Euglycemic Ketonuria

Normal saline (0.9% NaCl) is the appropriate initial fluid choice for a patient with mild ketonuria and euglycemia, as it provides effective hydration without exacerbating ketosis.

Understanding Euglycemic Ketosis

Euglycemic ketosis is characterized by the presence of ketones with normal blood glucose levels. This condition differs from classic diabetic ketoacidosis (DKA), which typically presents with hyperglycemia (>250 mg/dl), metabolic acidosis (pH <7.3), and ketonemia 1.

Key considerations for this case:

  • Ketone level of 1.3 indicates mild ketonuria
  • Euglycemia (normal blood glucose) is present
  • Patient requires hydration

Fluid Management Algorithm

  1. Initial fluid choice: 0.9% Normal Saline (NS)

    • Isotonic saline is the recommended first-line fluid for volume expansion and restoration of renal perfusion 2
    • For mild ketosis without acidosis, NS provides appropriate hydration without introducing glucose that could alter the metabolic state
  2. Rate of administration:

    • Adults: 15-20 ml/kg/hr for the first hour (typically 1-1.5 liters) 2
    • Subsequent rate should be adjusted based on:
      • Hydration status
      • Serum electrolyte levels
      • Urinary output
  3. Monitoring parameters:

    • Serum electrolytes
    • Blood glucose
    • Ketone levels
    • Urine output
    • Hemodynamic status

Rationale for Normal Saline Selection

Normal saline is preferred over other solutions for several reasons:

  1. Avoids exacerbating ketosis: Unlike dextrose-containing solutions, NS doesn't trigger insulin release that could mask ongoing ketosis 3

  2. Maintains electrolyte balance: NS provides sodium and chloride without affecting acid-base balance in mild cases 2

  3. Guideline-supported approach: Treatment protocols for ketotic states recommend isotonic saline as initial fluid therapy 2

  4. Prevents complications: Dextrose solutions can cause rapid shifts in osmolality and potentially worsen acidosis in ketotic states 3

When to Consider Alternative Fluids

  1. When to add dextrose:

    • Only after ketosis begins to resolve
    • When blood glucose falls below 250 mg/dl in DKA patients 2
    • Not indicated initially for euglycemic ketosis
  2. When to consider electrolyte supplementation:

    • After initial fluid resuscitation
    • Once renal function is assured
    • If serum potassium falls below 5.5 mEq/l 2

Important Clinical Considerations

  • Monitor for progression: Euglycemic ketosis can progress to euglycemic DKA, especially in patients taking SGLT-2 inhibitors 4, 1

  • Assess for underlying causes: Common triggers include decreased caloric intake, alcohol consumption, pregnancy, or SGLT-2 inhibitor use 1

  • Beta-hydroxybutyrate (β-OHB) monitoring: Direct measurement of β-OHB in blood is more reliable than urine ketone testing for monitoring response to therapy 5

  • Avoid common pitfalls:

    • Don't assume absence of ketoacidosis due to normal glucose levels
    • Don't use rapid dextrose infusions which can worsen metabolic derangements 3
    • Don't rely solely on urine ketones to monitor treatment response 5

Normal saline remains the safest initial choice for hydration in a patient with mild ketonuria and euglycemia, providing effective volume replacement while allowing for metabolic stabilization.

References

Research

Euglycemic Diabetic Ketoacidosis: A Review.

Current diabetes reviews, 2017

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

A Case of Euglycemic Diabetic Ketoacidosis due to Empagliflozin Use in a Patient with Type 1 Diabetes Mellitus.

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.